These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30446932)

  • 1. The effects of curcumin on the metabolic parameters of non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
    Wei Z; Liu N; Tantai X; Xing X; Xiao C; Chen L; Wang J
    Hepatol Int; 2019 May; 13(3):302-313. PubMed ID: 30446932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of curcumin supplementation on liver function, metabolic profile and body composition in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Jalali M; Mahmoodi M; Mosallanezhad Z; Jalali R; Imanieh MH; Moosavian SP
    Complement Ther Med; 2020 Jan; 48():102283. PubMed ID: 31987259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does turmeric/curcumin supplementation improve serum alanine aminotransferase and aspartate aminotransferase levels in patients with nonalcoholic fatty liver disease? A systematic review and meta-analysis of randomized controlled trials.
    Goodarzi R; Sabzian K; Shishehbor F; Mansoori A
    Phytother Res; 2019 Mar; 33(3):561-570. PubMed ID: 30653773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Yang K; Chen J; Zhang T; Yuan X; Ge A; Wang S; Xu H; Zeng L; Ge J
    Front Immunol; 2022; 13():949746. PubMed ID: 36159792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of Curcumin Supplementation on Metabolic Biomarkers and Body Mass Index in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Khalili L; Nammi S
    Curr Pharm Des; 2022; 28(23):1911-1925. PubMed ID: 35345991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Phytosomal Curcumin on Circulating Levels of Adiponectin and Leptin in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Mirhafez SR; Farimani AR; Dehhabe M; Bidkhori M; Hariri M; Ghouchani BF; Abdollahi F
    J Gastrointestin Liver Dis; 2019 Jun; 28():183-189. PubMed ID: 31204416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials.
    He XX; Wu XL; Chen RP; Chen C; Liu XG; Wu BJ; Huang ZM
    PLoS One; 2016; 11(10):e0162368. PubMed ID: 27711128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol Supplementation in Patients with Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-analysis.
    Elgebaly A; Radwan IA; AboElnas MM; Ibrahim HH; Eltoomy MF; Atta AA; Mesalam HA; Sayed AA; Othman AA
    J Gastrointestin Liver Dis; 2017 Mar; 26(1):59-67. PubMed ID: 28338115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D and non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
    Guo XF; Wang C; Yang T; Li S; Li KL; Li D
    Food Funct; 2020 Sep; 11(9):7389-7399. PubMed ID: 32966467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Nigella sativa in the treatment of nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Tang G; Zhang L; Tao J; Wei Z
    Phytother Res; 2021 Aug; 35(8):4183-4193. PubMed ID: 33728708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin as adjuvant treatment in patients with non-alcoholic fatty liver (NAFLD) disease: A systematic review and meta-analysis.
    Ngu MH; Norhayati MN; Rosnani Z; Zulkifli MM
    Complement Ther Med; 2022 Sep; 68():102843. PubMed ID: 35661765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of curcumin supplementation on body mass index, body weight, and waist circumference in patients with nonalcoholic fatty liver disease: A systematic review and dose-response meta-analysis of randomized controlled trials.
    Baziar N; Parohan M
    Phytother Res; 2020 Mar; 34(3):464-474. PubMed ID: 31799714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin Lowers Serum Lipids and Uric Acid in Subjects With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial.
    Panahi Y; Kianpour P; Mohtashami R; Jafari R; Simental-Mendía LE; Sahebkar A
    J Cardiovasc Pharmacol; 2016 Sep; 68(3):223-9. PubMed ID: 27124606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of vitamin D supplementation on metabolic profiles and liver function in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Tabrizi R; Moosazadeh M; Lankarani KB; Akbari M; Heydari ST; Kolahdooz F; Samimi M; Asemi Z
    Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S975-S982. PubMed ID: 28751149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of HuoXueHuaYu therapy for nonalcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trial.
    Cai Y; Liang Q; Chen W; Chen M; Chen R; Zhang Y; Xiao Y; Chen L
    BMC Complement Altern Med; 2019 Jul; 19(1):178. PubMed ID: 31324247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Resveratrol Supplementation against Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Placebo-Controlled Clinical Trials.
    Zhang C; Yuan W; Fang J; Wang W; He P; Lei J; Wang C
    PLoS One; 2016; 11(8):e0161792. PubMed ID: 27560482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dapagliflozin in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Sun L; Deng C; Gu Y; He Y; Yang L; Shi J
    Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101876. PubMed ID: 35321843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of novel metabolic targeted agents and natural plant drugs for nonalcoholic fatty liver disease treatment: A PRISMA-compliant network meta-analysis of randomized controlled trials.
    Zhou J; Chen Y; Yu J; Li T; Lu Z; Chen Y; Zhang X; Ye F
    Medicine (Baltimore); 2021 Mar; 100(12):e24884. PubMed ID: 33761646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty acid and non-alcoholic fatty liver disease: Meta-analyses of case-control and randomized controlled trials.
    Guo XF; Yang B; Tang J; Li D
    Clin Nutr; 2018 Feb; 37(1):113-122. PubMed ID: 28161092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial.
    Rahmani S; Asgary S; Askari G; Keshvari M; Hatamipour M; Feizi A; Sahebkar A
    Phytother Res; 2016 Sep; 30(9):1540-8. PubMed ID: 27270872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.